During the past decade, The Oncology Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Oncology Centre" #1 collaborator was "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator, "National Medical Research Council (NMRC), Singapore" with 1 trials as a collaborator and "PharmaEngine" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The Oncology Centre" are "Adult Soft Tissue Sarcoma" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Squamous Cell of Head and Neck" (1 trials). Many other conditions were trialed in "The Oncology Centre" in a lesser frequency.

Most popular intervention types in "The Oncology Centre" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "EG12014" (1 trials), "Herceptin" (1 trials), "NBTXR3" (1 trials), "Nimotuzumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Oncology Centre" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Oncology Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Oncology Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Oncology Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".